| Insider-Aktien | 9.981.306 shares |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Nettoanzahl der Insider, die kaufen (Rang)
N/A
Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).
Prozent des Streubesitzes von Insidern gekauft (Rang)
N/A
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
Avidity Biosciences, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in RNAM / Avidity Biosciences, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in RNAM / Avidity Biosciences, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | 2026-02-27 | 4 | McCarthy Teresa | RNAM | Common Stock | D | -165.296 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Thompson Tamar | RNAM | Common Stock | D | -6.692 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | MacLean Michael F | RNAM | Common Stock | D | -133.977 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Skerjanec Simona | RNAM | Common Stock | D | -6.692 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Boyce Sarah | RNAM | Common Stock | D | -474.861 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Hughes Steven George | RNAM | Common Stock | D | -115.857 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Moriarty John B | RNAM | Common Stock | D | -92.054 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Flanagan W. Michael | RNAM | Common Stock | D | -150.365 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | WILSON TROY EDWARD By family trust | RNAM | Common Stock | I | -13.711 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | WILSON TROY EDWARD | RNAM | Common Stock | D | -65.091 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Gallagher Kathleen P. | RNAM | Common Stock | D | -80.303 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Henig Noreen | RNAM | Common Stock | D | -6.692 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Kim Jean Jinsun | RNAM | Common Stock | D | -6.692 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | LEVIN ARTHUR A By family trust | RNAM | Common Stock | I | -131.372 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | LEVIN ARTHUR A | RNAM | Common Stock | D | -16.562 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Kaye Edward M. MD | RNAM | Common Stock | D | -6.692 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | BOESS CARSTEN | RNAM | Common Stock | D | -6.692 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Mosbrooker Eric | RNAM | Common Stock | D | -79.413 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Calderaro Charles III | RNAM | Common Stock | D | -98.547 | 0 | ||||||
| 2026-01-23 | 2026-01-21 | 4 | Hughes Steven George | RNA | Common Stock | D | 72,4500 | -2.878 | -209 | 31.599 | ||||
| 2026-01-23 | 2026-01-21 | 4 | Hughes Steven George | RNA | Common Stock | D | 72,4500 | -2.017 | -146 | 34.477 | ||||
| 2026-01-23 | 2026-01-21 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 72,4500 | -1.758 | -127 | 16.562 | ||||
| 2026-01-23 | 2026-01-21 | 4 | McCarthy Teresa | RNA | Common Stock | D | 72,4500 | -1.453 | -105 | 113.938 | ||||
| 2026-01-23 | 2026-01-21 | 4 | McCarthy Teresa | RNA | Common Stock | D | 72,4500 | -1.476 | -107 | 115.391 | ||||
| 2026-01-23 | 2026-01-21 | 4 | MacLean Michael F | RNA | Common Stock | D | 72,4500 | -2.735 | -198 | 59.290 | ||||
| 2026-01-23 | 2026-01-21 | 4 | MacLean Michael F | RNA | Common Stock | D | 72,4500 | -1.807 | -131 | 62.025 | ||||
| 2026-01-23 | 2026-01-21 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 72,4500 | -2.558 | -185 | 85.093 | ||||
| 2026-01-23 | 2026-01-21 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 72,4500 | -3.976 | -288 | 87.651 | ||||
| 2026-01-23 | 2026-01-21 | 4 | Boyce Sarah | RNA | Common Stock | D | 72,4500 | -7.993 | -579 | 269.007 | ||||
| 2026-01-23 | 2026-01-21 | 4 | Boyce Sarah | RNA | Common Stock | D | 72,4500 | -6.394 | -463 | 277.000 | ||||
| 2026-01-09 | 2026-01-07 | 4 | Moriarty John B | RNA | Common Stock | D | 72,2300 | -2.374 | -171 | 74.557 | ||||
| 2026-01-09 | 2026-01-07 | 4 | McCarthy Teresa | RNA | Common Stock | D | 72,2300 | -1.965 | -142 | 116.867 | ||||
| 2026-01-09 | 2026-01-07 | 4 | Calderaro Charles III | RNA | Common Stock | D | 72,2300 | -3.727 | -269 | 49.797 | ||||
| 2026-01-09 | 2026-01-07 | 4 | Boyce Sarah | RNA | Common Stock | D | 72,2300 | -8.576 | -619 | 283.394 | ||||
| 2026-01-09 | 2026-01-07 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 72,2300 | -2.373 | -171 | 91.627 | ||||
| 2026-01-09 | 2026-01-07 | 4 | Hughes Steven George | RNA | Common Stock | D | 72,2300 | -2.373 | -171 | 36.494 | ||||
| 2026-01-09 | 2026-01-07 | 4 | MacLean Michael F | RNA | Common Stock | D | 72,2300 | -1.974 | -143 | 63.832 | ||||
| 2025-12-22 | 2025-12-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | -1.330 | 18.320 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Calderaro Charles III | RNA | Common Stock | D | 71,8700 | -9.726 | -699 | 53.524 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Calderaro Charles III | RNA | Common Stock | D | 23.250 | 63.250 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 71,8700 | -13.695 | -984 | 94.000 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 27.500 | 107.695 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 71,8700 | -11.426 | -821 | 79.010 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 71,8700 | -36.564 | -2.628 | 90.436 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 72.000 | 127.000 | ||||||
| 2025-12-19 | 2025-12-18 | 4 | Boyce Sarah | RNA | Common Stock | D | -29.159 | 291.970 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Boyce Sarah | RNA | Common Stock | D | 71,8700 | -15.742 | -1.131 | 321.129 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Boyce Sarah | RNA | Common Stock | D | 31.000 | 336.871 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Moriarty John B | RNA | Common Stock | D | 71,8700 | -26.824 | -1.928 | 76.931 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Moriarty John B | RNA | Common Stock | D | 56.000 | 103.755 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 71,8700 | -8.030 | -577 | 80.838 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 71,8700 | -33.336 | -2.396 | 88.868 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 72.000 | 122.204 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | McCarthy Teresa | RNA | Common Stock | D | 71,8700 | -17.298 | -1.243 | 118.832 | ||||
| 2025-12-19 | 2025-12-17 | 4 | McCarthy Teresa | RNA | Common Stock | D | 39.000 | 136.130 | ||||||
| 2025-10-24 | 2025-10-22 | 4 | Hughes Steven George | RNA | Common Stock | D | 47,5394 | -2.209 | -105 | 38.867 | ||||
| 2025-10-24 | 2025-10-22 | 4 | Hughes Steven George | RNA | Common Stock | D | 10,1600 | 2.209 | 22 | 41.076 | ||||
| 2025-10-17 | 2025-10-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 50,1529 | -20.000 | -1.003 | 97.130 | ||||
| 2025-10-17 | 2025-10-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 22,3400 | 20.000 | 447 | 117.130 | ||||
| 2025-10-07 | 2025-10-03 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 45,3781 | -6.562 | -298 | 55.000 | ||||
| 2025-10-07 | 2025-10-03 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 9,0500 | 6.562 | 59 | 61.562 | ||||
| 2025-09-23 | 2025-09-22 | 4 | Hughes Steven George | RNA | Common Stock | D | 40,5800 | -2.208 | -90 | 38.867 | ||||
| 2025-09-23 | 2025-09-22 | 4 | Hughes Steven George | RNA | Common Stock | D | 10,1600 | 2.208 | 22 | 41.075 | ||||
| 2025-09-17 | 2025-09-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 41,4095 | -15.000 | -621 | 97.130 | ||||
| 2025-09-17 | 2025-09-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 22,3400 | 15.000 | 335 | 112.130 | ||||
| 2025-09-17 | 2025-09-15 | 4 | Hughes Steven George | RNA | Common Stock | D | 45,4100 | -1.542 | -70 | 38.867 | ||||
| 2025-09-17 | 2025-09-15 | 4 | Hughes Steven George | RNA | Common Stock | D | 6,5700 | 1.542 | 10 | 40.409 | ||||
| 2025-09-12 | 2025-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 38,9351 | -20.000 | -779 | 80.195 | ||||
| 2025-09-12 | 2025-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 14,2200 | 20.000 | 284 | 100.195 | ||||
| 2025-09-09 | 2025-09-05 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 50,0000 | -15.000 | -750 | 54.425 | ||||
| 2025-09-09 | 2025-09-05 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 50,0000 | -14.500 | -725 | 69.425 | ||||
| 2025-09-09 | 2025-09-05 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 12,4800 | 14.500 | 181 | 83.925 | ||||
| 2025-09-05 | 2025-09-05 | 4 | Boyce Sarah | RNA | Common Stock | D | 49,9487 | -50.000 | -2.497 | 305.871 | ||||
| 2025-09-05 | 2025-09-05 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 50.000 | 62 | 355.871 | ||||
| 2025-09-05 | 2025-09-03 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 47,0723 | -6.563 | -309 | 55.000 | ||||
| 2025-09-05 | 2025-09-03 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 9,0500 | 6.563 | 59 | 61.563 | ||||
| 2025-09-02 | 2025-09-02 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 47,4200 | -188 | -9 | 50.204 | ||||
| 2025-08-29 | 2025-08-28 | 4 | Boyce Sarah | RNA | Common Stock | D | 49,3880 | -25.000 | -1.235 | 305.871 | ||||
| 2025-08-29 | 2025-08-28 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 25.000 | 31 | 330.871 | ||||
| 2025-08-22 | 2025-08-22 | 4 | Hughes Steven George | RNA | Common Stock | D | 46,4047 | -2.208 | -102 | 38.867 | ||||
| 2025-08-22 | 2025-08-22 | 4 | Hughes Steven George | RNA | Common Stock | D | 10,1600 | 2.208 | 22 | 41.075 | ||||
| 2025-08-15 | 2025-08-13 | 4 | Hughes Steven George | RNA | Common Stock | D | 46,6600 | -1.542 | -72 | 38.867 | ||||
| 2025-08-15 | 2025-08-13 | 4 | Hughes Steven George | RNA | Common Stock | D | 6,5700 | 1.542 | 10 | 40.409 | ||||
| 2025-08-15 | 2025-08-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 42,7264 | -30.914 | -1.321 | 65.806 | ||||
| 2025-08-15 | 2025-08-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 46,5632 | -10.000 | -466 | 97.130 | ||||
| 2025-08-15 | 2025-08-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 22,3400 | 10.000 | 223 | 107.130 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 44,0626 | -6.120 | -270 | 55.000 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 44,0626 | -124.687 | -5.494 | 61.120 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 9,0500 | 124.687 | 1.128 | 185.807 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD By irrevocable trust 4 | RNA | Common Stock | I | 45,0000 | -17.777 | -800 | 17.776 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD By irrevocable trust 3 | RNA | Common Stock | I | 45,0000 | -17.777 | -800 | 17.776 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD By irrevocable trust 1 | RNA | Common Stock | I | 45,0000 | -15.000 | -675 | 285.000 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD By irrevocable trust 2 | RNA | Common Stock | I | 45,0000 | -15.000 | -675 | 285.000 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 45,0000 | -7.500 | -338 | 69.425 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 12,4800 | 7.500 | 94 | 76.925 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 45,0000 | -22.000 | -990 | 69.425 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 12,0300 | 22.000 | 265 | 91.425 | ||||
| 2025-08-08 | 2025-08-06 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 47,6175 | -107.500 | -5.119 | 19.650 | ||||
| 2025-08-08 | 2025-08-06 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,3400 | 107.500 | 2.402 | 127.150 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 42,7373 | -33.983 | -1.452 | 38.867 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 42,7373 | -17.667 | -755 | 72.850 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 10,1600 | 17.667 | 179 | 90.517 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 42,7373 | -6.167 | -264 | 72.850 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 22,4700 | 6.167 | 139 | 79.017 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 42,7373 | -12.334 | -527 | 72.850 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 6,5700 | 12.334 | 81 | 85.184 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 42,7373 | -11.283 | -482 | 72.850 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 15,9600 | 11.283 | 180 | 84.133 | ||||
| 2025-08-05 | 2025-08-04 | 4 | Moriarty John B | RNA | Common Stock | D | 36,2100 | -2.245 | -81 | 47.755 | ||||
| 2025-06-18 | 2025-06-17 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 30,2400 | -911 | -28 | 50.392 | ||||
| 2025-06-12 | 2025-06-10 | 4 | Henig Noreen | RNA | Common Stock | D | 6.692 | 6.692 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | BOESS CARSTEN | RNA | Common Stock | D | 6.692 | 6.692 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | Kaye Edward M. MD | RNA | Common Stock | D | 6.692 | 6.692 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 6.692 | 19.650 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | Skerjanec Simona | RNA | Common Stock | D | 6.692 | 6.692 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 6.692 | 69.425 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | Thompson Tamar | RNA | Common Stock | D | 6.692 | 6.692 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | Kim Jean Jinsun | RNA | Common Stock | D | 6.692 | 6.692 | ||||||
| 2025-06-12 | 2025-06-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 32,8847 | -20.000 | -658 | 80.195 | ||||
| 2025-06-12 | 2025-06-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 14,2200 | 20.000 | 284 | 100.195 | ||||
| 2025-06-04 | 2025-06-02 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 32,4822 | -5.875 | -191 | 50.554 | ||||
| 2025-06-04 | 2025-06-02 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 16,6500 | 5.875 | 98 | 56.429 | ||||
| 2025-05-02 | 2025-05-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 32,3956 | -5.875 | -190 | 50.554 | ||||
| 2025-05-02 | 2025-05-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 16,6500 | 5.875 | 98 | 56.429 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 27,8274 | -329 | -9 | 50.554 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 16,6500 | 329 | 5 | 50.883 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 27,8274 | -5.546 | -154 | 50.554 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 14,7000 | 5.546 | 82 | 56.100 | ||||
| 2025-03-21 | 2025-03-20 | 4 | Hughes Steven George | RNA | Common Stock | D | 31,0598 | -9.578 | -297 | 72.850 | ||||
| 2025-03-21 | 2025-03-20 | 4 | Boyce Sarah | RNA | Common Stock | D | 31,0578 | -31.540 | -980 | 305.871 | ||||
| 2025-03-21 | 2025-03-20 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 31,0584 | -11.780 | -366 | 80.195 | ||||
| 2025-03-21 | 2025-03-20 | 4 | MacLean Michael F | RNA | Common Stock | D | 31,0554 | -7.935 | -246 | 96.720 | ||||
| 2025-03-21 | 2025-03-20 | 4 | McCarthy Teresa | RNA | Common Stock | D | 31,0598 | -7.778 | -242 | 97.130 | ||||
| 2025-03-12 | 2025-03-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 30,1307 | -20.000 | -603 | 91.975 | ||||
| 2025-03-12 | 2025-03-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 14,2200 | 20.000 | 284 | 111.975 | ||||
| 2025-03-04 | 2025-03-03 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 29,4140 | -5.875 | -173 | 50.554 | ||||
| 2025-03-04 | 2025-03-03 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 14,7000 | 5.875 | 86 | 56.429 | ||||
| 2025-02-05 | 2025-02-03 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 32,1563 | -5.875 | -189 | 50.554 | ||||
| 2025-02-05 | 2025-02-03 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 16,6500 | 5.875 | 98 | 56.429 | ||||
| 2025-01-23 | 2025-01-21 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 28,5987 | -1.872 | -54 | 12.958 | ||||
| 2025-01-23 | 2025-01-21 | 4 | MacLean Michael F | RNA | Common Stock | D | 28,5932 | -1.665 | -48 | 104.655 | ||||
| 2025-01-23 | 2025-01-21 | 4 | MacLean Michael F | RNA | Common Stock | D | 28,5929 | -1.622 | -46 | 106.320 | ||||
| 2025-01-23 | 2025-01-21 | 4 | McCarthy Teresa | RNA | Common Stock | D | 28,5968 | -1.221 | -35 | 104.908 | ||||
| 2025-01-23 | 2025-01-21 | 4 | McCarthy Teresa | RNA | Common Stock | D | 28,5931 | -1.738 | -50 | 106.129 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 28,5920 | -1.812 | -52 | 91.975 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 28,5967 | -3.860 | -110 | 93.787 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Boyce Sarah | RNA | Common Stock | D | 28,5946 | -5.659 | -162 | 337.411 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Boyce Sarah | RNA | Common Stock | D | 28,5932 | -4.738 | -135 | 343.070 | ||||
| 2025-01-23 | 2025-01-22 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 30,1609 | -5.629 | -170 | 50.554 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 28,5930 | -1.817 | -52 | 56.183 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 28,5953 | -670 | -19 | 58.000 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 28,5900 | -1.295 | -37 | 58.670 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Hughes Steven George | RNA | Common Stock | D | 28,5906 | -2.032 | -58 | 82.428 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Hughes Steven George | RNA | Common Stock | D | 28,5955 | -1.915 | -55 | 84.460 | ||||
| 2025-01-08 | 2025-01-06 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 25.000 | 97.647 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25.000 | 107.867 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Moriarty John B | RNA | Common Stock | D | 25.000 | 50.000 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 25.000 | 107.942 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Boyce Sarah | RNA | Common Stock | D | 82.500 | 347.808 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 25.000 | 86.375 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 25.000 | 59.965 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 25.000 | 61.120 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Calderaro Charles III | RNA | Common Stock | D | 40.000 | 40.000 | ||||||
| 2025-01-08 | 3 | Mosbrooker Eric | RNA | Common Stock | D | 36.120 | ||||||||
| 2025-01-08 | 3 | Gallagher Kathleen P. | RNA | Common Stock | D | 34.965 | ||||||||
| 2025-01-08 | 3 | Hughes Steven George | RNA | Common Stock | D | 61.375 | ||||||||
| 2024-12-19 | 2024-12-18 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 32,6600 | -12.742 | -416 | 72.647 | ||||
| 2024-12-19 | 2024-12-18 | 4 | Boyce Sarah | RNA | Common Stock | D | 32,6600 | -31.855 | -1.040 | 265.308 | ||||
| 2024-12-19 | 2024-12-18 | 4 | MacLean Michael F | RNA | Common Stock | D | 32,6600 | -11.151 | -364 | 82.942 | ||||
| 2024-12-19 | 2024-12-18 | 4 | McCarthy Teresa | RNA | Common Stock | D | 32,6600 | -11.151 | -364 | 82.867 | ||||
| 2024-12-18 | 2024-12-16 | 4 | McCarthy Teresa | RNA | Common Stock | D | 33,2642 | -25.000 | -832 | 94.018 | ||||
| 2024-12-18 | 2024-12-16 | 4 | McCarthy Teresa | RNA | Common Stock | D | 14,2200 | 25.000 | 356 | 119.018 | ||||
| 2024-12-13 | 2024-12-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 35,7667 | -24.000 | -858 | 85.389 | ||||
| 2024-12-13 | 2024-12-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 22,4700 | 24.000 | 539 | 109.389 | ||||
| 2024-11-20 | 2024-11-18 | 4 | McCarthy Teresa | RNA | Common Stock | D | 41,1408 | -25.000 | -1.029 | 94.018 | ||||
| 2024-11-20 | 2024-11-18 | 4 | McCarthy Teresa | RNA | Common Stock | D | 14,2200 | 25.000 | 356 | 119.018 | ||||
| 2024-11-20 | 2024-11-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 42,1224 | -3.323 | -140 | 14.830 | ||||
| 2024-11-20 | 2024-11-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 3.323 | 4 | 18.153 | ||||
| 2024-11-08 | 2024-11-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 45,3339 | -13.875 | -629 | 94.093 | ||||
| 2024-11-08 | 2024-11-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 6,5700 | 13.875 | 91 | 107.968 | ||||
| 2024-11-08 | 2024-11-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 45,3339 | -65.182 | -2.955 | 94.093 | ||||
| 2024-11-08 | 2024-11-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 8,8200 | 65.182 | 575 | 159.275 | ||||
| 2024-11-08 | 2024-11-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 46,2188 | -27.262 | -1.260 | 94.093 | ||||
| 2024-10-23 | 2024-10-21 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 46,6335 | -5.000 | -233 | 14.830 | ||||
| 2024-10-23 | 2024-10-21 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5.000 | 6 | 19.830 | ||||
| 2024-10-17 | 2024-10-16 | 4 | McCarthy Teresa | RNA | Common Stock | D | 48,5204 | -25.000 | -1.213 | 94.018 | ||||
| 2024-10-17 | 2024-10-16 | 4 | McCarthy Teresa | RNA | Common Stock | D | 14,2200 | 25.000 | 356 | 119.018 | ||||
| 2024-10-09 | 2024-10-07 | 4 | Thompson Tamar | RNA | Common Stock | D | 44,9753 | -30.000 | -1.349 | 0 | ||||
| 2024-10-09 | 2024-10-07 | 4 | Thompson Tamar | RNA | Common Stock | D | 27,6300 | 30.000 | 829 | 30.000 | ||||
| 2024-10-03 | 2024-10-01 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 47,6178 | -62.500 | -2.976 | 85.389 | ||||
| 2024-10-03 | 2024-10-01 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 26,7500 | 62.500 | 1.672 | 147.889 | ||||
| 2024-09-23 | 2024-09-23 | 4 | McCarthy Teresa | RNA | Common Stock | D | 44,0004 | -13.153 | -579 | 69.018 | ||||
| 2024-09-23 | 2024-09-19 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25.000 | 94.018 | ||||||
| 2024-09-23 | 2024-09-19 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25.000 | 94.018 | ||||||
| 2024-09-23 | 2024-09-23 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 43,8926 | -11.847 | -520 | 85.389 | ||||
| 2024-09-23 | 2024-09-23 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 44,0004 | -13.153 | -579 | 72.718 | ||||
| 2024-09-23 | 2024-09-19 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 25.000 | 97.718 | ||||||
| 2024-09-23 | 2024-09-19 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 25.000 | 97.718 | ||||||
| 2024-09-23 | 2024-09-23 | 4 | Boyce Sarah | RNA | Common Stock | D | 44,0001 | -32.880 | -1.447 | 234.663 | ||||
| 2024-09-23 | 2024-09-19 | 4 | Boyce Sarah | RNA | Common Stock | D | 62.500 | 297.163 | ||||||
| 2024-09-23 | 2024-09-19 | 4 | Boyce Sarah | RNA | Common Stock | D | 62.500 | 297.163 | ||||||
| 2024-09-23 | 2024-09-23 | 4 | MacLean Michael F | RNA | Common Stock | D | 44,0000 | -11.510 | -506 | 96.355 | ||||
| 2024-09-23 | 2024-09-19 | 4 | MacLean Michael F | RNA | Common Stock | D | 25.000 | 121.355 | ||||||
| 2024-09-23 | 2024-09-19 | 4 | MacLean Michael F | RNA | Common Stock | D | 25.000 | 121.355 | ||||||
| 2024-09-20 | 2024-09-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 45,7316 | -5.000 | -229 | 14.830 | ||||
| 2024-09-20 | 2024-09-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5.000 | 6 | 19.830 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 40,3972 | -14.894 | -602 | 60.871 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 40,3987 | -34.000 | -1.374 | 75.765 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 22,4700 | 34.000 | 764 | 109.765 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 40,4002 | -62.500 | -2.525 | 75.765 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 26,7500 | 62.500 | 1.672 | 138.265 | ||||
| 2024-09-13 | 2024-09-11 | 4 | McCarthy Teresa | RNA | Common Stock | D | 40,4017 | -25.000 | -1.010 | 57.171 | ||||
| 2024-09-13 | 2024-09-11 | 4 | McCarthy Teresa | RNA | Common Stock | D | 14,2200 | 25.000 | 356 | 82.171 | ||||
| 2024-09-10 | 2024-09-06 | 4 | LEVIN ARTHUR A By charitable remainder trust | RNA | Common Stock | I | 22.500 | 22.500 | ||||||
| 2024-09-10 | 2024-09-06 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | -22.500 | 131.372 | ||||||
| 2024-08-21 | 2024-08-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 45,1893 | -5.000 | -226 | 14.830 | ||||
| 2024-08-21 | 2024-08-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5.000 | 6 | 19.830 | ||||
| 2024-08-07 | 2024-08-06 | 4 | Boyce Sarah | RNA | Common Stock | D | 43,3508 | -28.000 | -1.214 | 205.043 | ||||
| 2024-08-07 | 2024-08-06 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28.000 | 35 | 233.043 | ||||
| 2024-08-05 | 2024-08-01 | 4 | Moriarty John B | RNA | Common Stock | D | 25.000 | 25.000 | ||||||
| 2024-07-23 | 2024-07-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 45,0138 | -5.000 | -225 | 14.830 | ||||
| 2024-07-23 | 2024-07-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5.000 | 6 | 19.830 | ||||
| 2024-07-11 | 2024-07-09 | 4 | Boyce Sarah | RNA | Common Stock | D | 39,9315 | -28.000 | -1.118 | 205.043 | ||||
| 2024-07-11 | 2024-07-09 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28.000 | 35 | 233.043 | ||||
| 2024-06-21 | 2024-06-20 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 37,5901 | -5.000 | -188 | 14.830 | ||||
| 2024-06-21 | 2024-06-20 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5.000 | 6 | 19.830 | ||||
| 2024-06-20 | 2024-06-18 | 4 | McCarthy Teresa | RNA | Common Stock | D | 39,1294 | -9.864 | -386 | 32.171 | ||||
| 2024-06-20 | 2024-06-17 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25.000 | 57.171 | ||||||
| 2024-06-20 | 2024-06-17 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25.000 | 57.171 | ||||||
| 2024-06-20 | 2024-06-18 | 4 | Boyce Sarah | RNA | Common Stock | D | 39,1295 | -32.074 | -1.255 | 142.543 | ||||
| 2024-06-20 | 2024-06-17 | 4 | Boyce Sarah | RNA | Common Stock | D | 62.500 | 205.043 | ||||||
| 2024-06-20 | 2024-06-17 | 4 | Boyce Sarah | RNA | Common Stock | D | 62.500 | 205.043 | ||||||
| 2024-06-20 | 2024-06-18 | 4 | MacLean Michael F | RNA | Common Stock | D | 39,1294 | -11.228 | -439 | 57.865 | ||||
| 2024-06-20 | 2024-06-17 | 4 | MacLean Michael F | RNA | Common Stock | D | 25.000 | 82.865 | ||||||
| 2024-06-20 | 2024-06-17 | 4 | MacLean Michael F | RNA | Common Stock | D | 25.000 | 82.865 | ||||||
| 2024-06-20 | 2024-06-18 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 39,1297 | -10.106 | -395 | 50.765 | ||||
| 2024-06-20 | 2024-06-17 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 25.000 | 75.765 | ||||||
| 2024-06-20 | 2024-06-17 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 25.000 | 75.765 | ||||||
| 2024-06-14 | 2024-06-12 | 4 | MacLean Michael F | RNA | Common Stock | D | 35,7153 | -104.245 | -3.723 | 44.093 | ||||
| 2024-06-14 | 2024-06-12 | 4 | MacLean Michael F | RNA | Common Stock | D | 8,8200 | 104.245 | 919 | 148.338 | ||||
| 2024-06-14 | 2024-06-13 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 40,0797 | -60.000 | -2.405 | 153.872 | ||||
| 2024-06-14 | 2024-06-12 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 35,0657 | -40.000 | -1.403 | 213.872 | ||||
| 2024-06-14 | 2024-06-14 | 4 | Boyce Sarah | RNA | Common Stock | D | 40,0784 | -35.767 | -1.433 | 112.117 | ||||
| 2024-06-14 | 2024-06-14 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 35.767 | 44 | 147.884 | ||||
| 2024-06-14 | 2024-06-13 | 4 | Boyce Sarah | RNA | Common Stock | D | 40,0760 | -164.233 | -6.582 | 112.117 | ||||
| 2024-06-14 | 2024-06-13 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 164.233 | 204 | 276.350 | ||||
| 2024-06-14 | 2024-06-12 | 4 | Boyce Sarah | RNA | Common Stock | D | 35,7302 | -100.000 | -3.573 | 112.117 | ||||
| 2024-06-14 | 2024-06-12 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 100.000 | 124 | 212.117 | ||||
| 2024-06-05 | 2024-06-04 | 4 | Boyce Sarah | RNA | Common Stock | D | 27,4207 | -28.000 | -768 | 112.117 | ||||
| 2024-06-05 | 2024-06-04 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28.000 | 35 | 140.117 | ||||
| 2024-05-21 | 2024-05-20 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 29,8962 | -5.000 | -149 | 14.830 | ||||
| 2024-05-21 | 2024-05-20 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5.000 | 6 | 19.830 | ||||
| 2024-05-16 | 2024-05-14 | 4 | MacLean Michael F | RNA | Common Stock | D | 28,2806 | -75.000 | -2.121 | 44.093 | ||||
| 2024-05-16 | 2024-05-14 | 4 | MacLean Michael F | RNA | Common Stock | D | 8,8200 | 75.000 | 662 | 119.093 | ||||
| 2024-05-07 | 2024-05-07 | 4 | Boyce Sarah | RNA | Common Stock | D | 25,5375 | -28.000 | -715 | 112.117 | ||||
| 2024-05-07 | 2024-05-07 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28.000 | 35 | 140.117 | ||||
| 2024-04-22 | 2024-04-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,8246 | -5.000 | -114 | 14.830 | ||||
| 2024-04-22 | 2024-04-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5.000 | 6 | 19.830 | ||||
| 2024-04-03 | 2024-04-03 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 27,1107 | -20.000 | -542 | 253.872 | ||||
| 2024-04-03 | 2024-04-02 | 4 | Boyce Sarah | RNA | Common Stock | D | 26,2471 | -28.000 | -735 | 112.117 | ||||
| 2024-04-03 | 2024-04-02 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28.000 | 35 | 140.117 | ||||
| 2024-03-21 | 2024-03-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 23,9695 | -5.000 | -120 | 14.830 | ||||
| 2024-03-21 | 2024-03-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5.000 | 6 | 19.830 | ||||
| 2024-03-15 | 2024-03-13 | 4 | MacLean Michael F | RNA | Common Stock | D | 24,5190 | -40.000 | -981 | 44.093 | ||||
| 2024-03-15 | 2024-03-13 | 4 | MacLean Michael F | RNA | Common Stock | D | 8,8200 | 40.000 | 353 | 84.093 | ||||
| 2024-03-12 | 2024-03-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0000 | -2.641 | -58 | 14.830 | ||||
| 2024-03-12 | 2024-03-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0366 | -25.000 | -551 | 17.471 | ||||
| 2024-03-12 | 2024-03-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 25.000 | 31 | 42.471 | ||||
| 2024-03-12 | 2024-03-12 | 4 | Boyce Sarah | RNA | Common Stock | D | 22,6315 | -28.000 | -634 | 112.117 | ||||
| 2024-03-12 | 2024-03-12 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28.000 | 35 | 140.117 | ||||
| 2024-03-12 | 2024-03-08 | 4 | Boyce Sarah | RNA | Common Stock | D | 21,3894 | -84.000 | -1.797 | 112.117 | ||||
| 2024-03-12 | 2024-03-08 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 84.000 | 104 | 196.117 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Boyce Sarah | RNA | Common Stock | D | 20,1346 | -84.000 | -1.691 | 112.117 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 84.000 | 104 | 196.117 | ||||
| 2024-01-23 | 2024-01-22 | 4 | Boyce Sarah | RNA | Common Stock | D | 10,1300 | -5.092 | -52 | 44.008 | ||||
| 2024-01-23 | 2024-01-20 | 4 | Boyce Sarah | RNA | Common Stock | D | 62.500 | 67.209 | ||||||
| 2024-01-23 | 2024-01-22 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 10,1300 | -1.859 | -19 | 17.471 | ||||
| 2024-01-23 | 2024-01-22 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 10,1300 | -4.129 | -42 | 35.871 | ||||
| 2024-01-23 | 2024-01-20 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 20.000 | 20.290 | ||||||
| 2024-01-23 | 2024-01-22 | 4 | McCarthy Teresa | RNA | Common Stock | D | 10,1300 | -2.065 | -21 | 17.035 | ||||
| 2024-01-23 | 2024-01-20 | 4 | McCarthy Teresa | RNA | Common Stock | D | 16.500 | 17.458 | ||||||
| 2024-01-23 | 2024-01-22 | 4 | MacLean Michael F | RNA | Common Stock | D | 10,1300 | -1.616 | -16 | 16.884 | ||||
| 2024-01-23 | 2024-01-20 | 4 | MacLean Michael F | RNA | Common Stock | D | 22.500 | 27.209 | ||||||
| 2023-12-14 | 2023-12-12 | 4 | WILSON TROY EDWARD By trust FBO Children 3 and 4 | RNA | Common Stock | I | 250.000 | 300.000 | ||||||
| 2023-12-14 | 2023-12-12 | 4 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | -250.000 | 13.711 | ||||||
| 2023-12-14 | 2023-12-12 | 4 | WILSON TROY EDWARD By trust FBO Children 1 and 2 | RNA | Common Stock | I | 300.000 | 300.000 | ||||||
| 2023-12-14 | 2023-12-12 | 4 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | -300.000 | 263.711 | ||||||
| 2023-03-17 | 2023-03-15 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0100 | -100 | -2 | 19.330 | ||||
| 2023-03-17 | 2023-03-15 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 100 | 0 | 19.430 | ||||
| 2023-02-15 | 2023-02-14 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 24,2381 | -523 | -13 | 19.330 | ||||
| 2023-02-15 | 2023-02-14 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 23,6246 | -9.477 | -224 | 19.853 | ||||
| 2023-02-15 | 2023-02-14 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 10.000 | 12 | 29.330 | ||||
| 2023-02-03 | 2023-02-03 | 4 | Boyce Sarah | RNA | Common Stock | D | 24,2600 | -3.221 | -78 | 53.352 | ||||
| 2023-02-03 | 2023-02-03 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 3.221 | 4 | 56.573 | ||||
| 2023-02-03 | 2023-02-02 | 4 | Boyce Sarah | RNA | Common Stock | D | 24,3628 | -45.879 | -1.118 | 53.352 | ||||
| 2023-02-03 | 2023-02-02 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 45.879 | 57 | 99.231 | ||||
| 2023-02-03 | 2023-02-01 | 4 | Boyce Sarah | RNA | Common Stock | D | 24,2716 | -900 | -22 | 53.352 | ||||
| 2023-02-03 | 2023-02-01 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 900 | 1 | 54.252 | ||||
| 2023-01-24 | 2023-01-20 | 4 | Boyce Sarah | RNA | Common Stock | D | 50.000 | 53.352 | ||||||
| 2023-01-24 | 2023-01-20 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 40.000 | 40.290 | ||||||
| 2023-01-24 | 2023-01-20 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 18.000 | 19.330 | ||||||
| 2023-01-24 | 2023-01-20 | 4 | MacLean Michael F | RNA | Common Stock | D | 18.500 | 21.852 | ||||||
| 2023-01-24 | 2023-01-20 | 4 | McCarthy Teresa | RNA | Common Stock | D | 20.000 | 20.958 | ||||||
| 2023-01-17 | 2023-01-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0028 | -10.000 | -220 | 1.330 | ||||
| 2023-01-17 | 2023-01-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 10.000 | 12 | 11.330 | ||||
| 2023-01-03 | 2022-12-29 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0142 | -40.000 | -881 | 1.330 | ||||
| 2023-01-03 | 2022-12-29 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 40.000 | 50 | 41.330 | ||||
| 2022-08-31 | 2022-08-16 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0798 | -3.499 | -77 | 1.330 | ||||
| 2022-08-31 | 2022-08-16 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 3.499 | 4 | 4.829 | ||||
| 2022-08-31 | 2022-08-15 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,1182 | -62.498 | -1.382 | 1.330 | ||||
| 2022-08-31 | 2022-08-15 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 34.758 | 43 | 63.828 | ||||
| 2022-08-31 | 2022-08-15 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 0,5300 | 27.740 | 15 | 29.070 | ||||
| 2022-08-31 | 2022-08-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0000 | -14.003 | -308 | 1.330 | ||||
| 2022-08-31 | 2022-08-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 0,5300 | 14.003 | 7 | 15.333 | ||||
| 2022-08-26 | 2022-08-25 | 4 | Boyce Sarah | RNA | Common Stock | D | 23,0690 | -14.855 | -343 | 0 | ||||
| 2022-08-26 | 2022-08-25 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 14.855 | 18 | 14.855 | ||||
| 2022-08-26 | 2022-08-24 | 4 | Boyce Sarah | RNA | Common Stock | D | 22,7971 | -35.045 | -799 | 0 | ||||
| 2022-08-26 | 2022-08-24 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 35.045 | 43 | 35.045 | ||||
| 2022-08-17 | 2022-08-15 | 4 | Boyce Sarah | RNA | Common Stock | D | 22,4700 | -100 | -2 | 0 | ||||
| 2022-08-17 | 2022-08-15 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 100 | 0 | 100 | ||||
| 2022-03-15 | 2022-01-21 | 4 | McCarthy Teresa | RNA | Stock Option (Right to Buy) | D | 14,22 | 157.500 | 157.500 | |||||
| 2022-03-15 | 2022-01-21 | 4 | Flanagan W. Michael | RNA | Stock Option (Right to Buy) | D | 14,22 | 136.500 | 136.500 | |||||
| 2022-03-15 | 2022-01-21 | 4 | MacLean Michael F | RNA | Stock Option (Right to Buy) | D | 14,22 | 131.250 | 131.250 | |||||
| 2022-03-15 | 2022-01-21 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 14,22 | 115.500 | 115.500 | |||||
| 2022-03-15 | 2022-01-21 | 4 | Boyce Sarah | RNA | Stock Option (Right to Buy) | D | 14,22 | 425.000 | 425.000 | |||||
| 2021-11-22 | 2021-11-18 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 0,53 | -604 | 41.743 | |||||
| 2021-11-22 | 2021-11-18 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 1,24 | -24.396 | 166.770 | |||||
| 2021-11-22 | 2021-11-18 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 27,8887 | -25.000 | -697 | 1.330 | ||||
| 2021-11-22 | 2021-11-18 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 0,5300 | 604 | 0 | 26.330 | ||||
| 2021-11-22 | 2021-11-18 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 24.396 | 30 | 25.726 | ||||
| 2021-08-27 | 2021-08-25 | 4 | Mosbrooker Eric | RNA | Stock Option (Right to Buy) | D | 20,83 | 30.000 | 30.000 | |||||
| 2021-08-06 | 2021-08-04 | 4 | RTW INVESTMENTS, LP By RTW | RNA | Common Stock | I | 18,0000 | 800.000 | 14.400 | 4.795.000 | ||||
| 2021-08-06 | 2020-06-11 | 4 | RTW INVESTMENTS, LP By RTW | RNA | Series C Preferred Stock | I | -3.995.000 | 0 | ||||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 0,53 | -3.083 | 42.347 | |||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 1,24 | -17.017 | 191.166 | |||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 29,1398 | -2.647 | -77 | 1.330 | ||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 27,9703 | -17.453 | -488 | 3.977 | ||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 0,5300 | 3.083 | 2 | 21.430 | ||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 17.017 | 21 | 18.347 | ||||
| 2021-06-28 | 2021-06-24 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 1,24 | -100 | 208.183 | |||||
| 2021-06-28 | 2021-06-24 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 27,7550 | -100 | -3 | 1.330 | ||||
| 2021-06-28 | 2021-06-24 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 100 | 0 | 1.430 | ||||
| 2021-06-22 | 2021-06-17 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 1,24 | -200 | 208.283 | |||||
| 2021-06-22 | 2021-06-17 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 27,7500 | -200 | -6 | 1.330 | ||||
| 2021-06-22 | 2021-06-17 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 200 | 0 | 1.530 | ||||
| 2021-06-17 | 2021-06-16 | 4 | WONG RODERICK | RNA | Stock Option (Right to Buy) | D | 26,09 | 15.000 | 15.000 | |||||
| 2021-06-16 | 2021-06-15 | 4 | LEVIN ARTHUR A By charitable remainder trust | RNA | Common Stock | I | 26,0249 | -23.019 | -599 | 0 | ||||
| 2021-06-16 | 2021-06-14 | 4 | LEVIN ARTHUR A By charitable remainder trust | RNA | Common Stock | I | 25,9174 | -14.003 | -363 | 23.019 | ||||
| 2021-06-16 | 2021-06-16 | 4 | WILSON TROY EDWARD | RNA | Stock Option (Right to Buy) | D | 26,09 | 15.000 | 15.000 | |||||
| 2021-06-16 | 2021-06-16 | 4 | Kaye Edward M. MD | RNA | Stock Option (Right to Buy) | D | 26,09 | 15.000 | 15.000 | |||||
| 2021-06-16 | 2021-06-16 | 4 | Henig Noreen | RNA | Stock Option (Right to Buy) | D | 26,09 | 15.000 | 15.000 | |||||
| 2021-06-16 | 2021-06-16 | 4 | BOESS CARSTEN | RNA | Stock Option (Right to Buy) | D | 26,09 | 15.000 | 15.000 | |||||
| 2021-03-18 | 2021-03-16 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 0,53 | -1.975 | 45.430 | |||||
| 2021-03-18 | 2021-03-16 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 1,24 | -2.625 | 208.483 | |||||
| 2021-03-18 | 2021-03-16 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 27,8655 | -4.600 | -128 | 0 | ||||
| 2021-03-18 | 2021-03-16 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 0,5300 | 1.975 | 1 | 4.600 | ||||
| 2021-03-18 | 2021-03-16 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 2.625 | 3 | 2.625 | ||||
| 2021-03-18 | 2021-03-05 | 4 | LEVIN ARTHUR A By charitable remainder trust | RNA | Common Stock | I | 37.022 | 37.022 | ||||||
| 2021-03-18 | 2021-03-05 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | -37.022 | 273.872 | ||||||
| 2021-02-04 | 2021-02-02 | 4 | Boyce Sarah | RNA | Stock Option (Right to Buy) | D | 22,34 | 300.000 | 300.000 | |||||
| 2021-02-04 | 2021-02-02 | 4 | MacLean Michael F | RNA | Stock Option (Right to Buy) | D | 22,34 | 92.000 | 92.000 | |||||
| 2021-02-04 | 2021-02-02 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 22,34 | 120.000 | 120.000 | |||||
| 2021-02-04 | 2021-02-02 | 4 | Kim Jae B. | RNA | Stock Option (Right to Buy) | D | 22,34 | 82.000 | 82.000 | |||||
| 2021-02-04 | 2021-02-02 | 4 | Baroldi Joseph | RNA | Stock Option (Right to Buy) | D | 22,34 | 87.000 | 87.000 | |||||
| 2021-01-25 | 2021-01-21 | 4 | Flanagan W. Michael | RNA | Stock Option (Right to Buy) | D | 26,75 | 150.000 | 150.000 | |||||
| 2021-01-11 | 2021-01-11 | 4 | Kim Jean Jinsun | RNA | Stock Option (Right to Buy) | D | 27,63 | 30.000 | 30.000 | |||||
| 2021-01-11 | 2021-01-11 | 4 | Thompson Tamar | RNA | Stock Option (Right to Buy) | D | 27,63 | 30.000 | 30.000 | |||||
| 2020-12-28 | 2020-12-22 | 4 | WILSON TROY EDWARD By family trust 2 | RNA | Common Stock | I | 100.000 | 100.000 | ||||||
| 2020-12-28 | 2020-12-22 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | -100.000 | 89.618 | ||||||
| 2020-07-27 | 2020-07-27 | 4 | Kim Jae B. | RNA | Stock Option (Right to Buy) | D | 25,05 | 375.266 | 375.266 | |||||
| 2020-06-18 | 2020-06-16 | 4 | Cormorant Asset Management, LLC | RNA | Series C Convertible Preferred Stock | D | 2.214.545 | 0 | ||||||
| 2020-06-18 | 2020-06-16 | 4 | Cormorant Asset Management, LLC See Footnotes | RNA | Common Stock | I | 18,0000 | 300.000 | 5.400 | 2.514.545 | ||||
| 2020-06-18 | 2020-06-16 | 4 | Cormorant Asset Management, LLC See Footnotes | RNA | Common Stock | I | 2.214.545 | 2.214.545 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | LILLY ELI & CO | RNA | Series C Preferred Stock | D | -4.576.342 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | LILLY ELI & CO | RNA | Common Stock | D | 2.169.396 | 2.169.396 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | Alexandria Venture Investments, LLC | RNA | Series C convertible preferred stock | D | -134.126 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | Alexandria Venture Investments, LLC | RNA | Series B convertible preferred stock | D | -530.616 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | Alexandria Venture Investments, LLC | RNA | Series A convertible preferred stock | D | -395.000 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | Alexandria Venture Investments, LLC | RNA | Common stock | D | 502.365 | 502.365 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | LEVIN ARTHUR A By family trust | RNA | Series A Preferred Stock | I | -35.337 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 16.751 | 310.894 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | RTW INVESTMENTS, LP By RTW Investments, LP | RNA | Series C Preferred Stock | I | -6.423.431 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | RTW INVESTMENTS, LP By RTW Investments, LP | RNA | Common Stock | I | 18,0000 | 950.000 | 17.100 | 3.995.000 | ||||
| 2020-06-16 | 2020-06-16 | 4 | RTW INVESTMENTS, LP By RTW Investments, LP | RNA | Common Stock | I | 3.045.000 | 3.045.000 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | WILSON TROY EDWARD By family trust | RNA | Series C Preferred Stock | I | -108.504 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | WILSON TROY EDWARD By family trust | RNA | Series B Preferred Stock | I | -35.374 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | WILSON TROY EDWARD By family trust | RNA | Series A Preferred Stock | I | -254.907 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | 189.042 | 805.301 | ||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD | RNA | Common Stock | D | 1.090.303 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 4 | RNA | Common Stock | I | 912.536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 3 | RNA | Common Stock | I | 912.536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 2 | RNA | Common Stock | I | 936.238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 1 | RNA | Common Stock | I | 936.238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | 1.516.944 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD | RNA | Common Stock | D | 1.090.303 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 1 | RNA | Common Stock | I | 936.238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 2 | RNA | Common Stock | I | 936.238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD | RNA | Common Stock | D | 1.090.303 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | 1.516.944 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 1 | RNA | Common Stock | I | 936.238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 2 | RNA | Common Stock | I | 936.238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 3 | RNA | Common Stock | I | 912.536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 4 | RNA | Common Stock | I | 912.536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 3 | RNA | Common Stock | I | 912.536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 4 | RNA | Common Stock | I | 912.536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | 1.516.944 | ||||||||
| 2020-06-11 | 3 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 588.286 | ||||||||
| 2020-06-11 | 3 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 588.286 | ||||||||
| 2020-06-11 | 3 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 588.286 |
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
